VisEn Medical expands FMT imaging platform

Download PDF Copy

Apr 16 2010

VisEn Medical Inc., a leader in fluorescence imaging solutions from research through medicine, announced today that it has expanded its leading FMT imaging platform with an FMT™ Multi-Species Imaging Module, to extend FMT imaging and related applications into larger preclinical animal models. VisEn also announced that it will be presenting new study results from its recently-launched Cat B 750 FAST™ and Annexin-Vivo™ fluorescence imaging agents at the AACR (American Association of Cancer Research) 101st Annual Meeting, highlighting translational imaging advances in leading oncology research. The AACR Annual Meeting is being held in Washington, DC from April 17 – 21, 2010.

Source:

VisEn Medical Inc.

Posted in: Drug Trial News | Device / Technology News | Medical Condition News

Tags: Apoptosis, Arthritis, Atherosclerosis, Biomarker, Bone, Cancer, Cardiovascular Disease, Cirrhosis, Fluorescence, Fluorescence Imaging, Imaging, Medicine, Metastasis, Obesity, Oncology, Preclinical, Research, Stroke, Toxicology

Comments (0)

Download PDF Copy

Suggested Reading

Natural nutrients nicotinamide and pyridoxine reverse muscle aging

Natural nutrients nicotinamide and pyridoxine reverse muscle aging

Portable MRI and AI improve Alzheimer’s diagnosis with cost-effective precision

Portable MRI and AI improve Alzheimer’s diagnosis with cost-effective precision

Metabolic imaging detects ovarian cancer subtypes and predicts chemotherapy response

Metabolic imaging detects ovarian cancer subtypes and predicts chemotherapy response

SARS-CoV-2 spike protein found lingering in brain regions

SARS-CoV-2 spike protein found lingering in brain regions

Gut microbiome and brain evolution: New insights into energy allocation

Gut microbiome and brain evolution: New insights into energy allocation

Key plasma proteins signal critical periods in brain aging

Key plasma proteins signal critical periods in brain aging

Tea, apples, and chocolate proven to support liver health

Tea, apples, and chocolate proven to support liver health

AI-powered MRI predicts outcomes in prostate cancer

AI-powered MRI predicts outcomes in prostate cancer

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

How AI is advancing mammographic density-based breast cancer risk prediction